S. Muoio & Co. LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

S. Muoio & Co. LLC

$75.7 Million
Q3 2022

A detailed history of S. Muoio & Co. LLC transactions in Biohaven Pharmaceutical Holding CO Ltd. stock. As of the latest transaction made, S. Muoio & Co. LLC holds 18,980 shares of BHVN stock, worth $1.01 Million. This represents 3.79% of its overall portfolio holdings.

Number of Shares

18,980

Previous 13,500 40.59%

Holding current value

$1.01 Million

Previous $1.97 Million 45.86%

% of portfolio

3.79%

Previous 2.8%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2022 Nov 14, 2022	BUY	$144.95 - $152.29 $794,325 - $834,549	5,480 Added 40.59%	18,980 $2.87 Million
Q2 2022 Aug 15, 2022	BUY	$83.14 - $145.99 $1.12 Million - $1.97 Million	13,500 New	13,500 $1.97 Million

Others Institutions Holding BHVN

# of Institutions

Shares Held

785K

Call Options Held

Put Options Held

View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.8B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

More about BHVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of S. Muoio & Co. LLC, based on Form 13F filings with the SEC.

News

Stay updated on S. Muoio & Co. LLC with notifications on news.

Account